Hot Topic Webinars


To share pharmacoepidemiological learnings from own research.


8 scheduled presentations per year (posted here on DSFE’s homepage). Each session lasts 45 minutes and covers one specific paper and one theoretical topic. The theoretical presentation will constitute no more than 10 minutes and cover an issue related to the paper but presented in its own right, e.g. surveillance bias, propensity score adjustment, or reverse causation. The presentation of the paper focuses on the methods applied and the analytical choices made during the project (and their underlying rationale). The aim is to give a pragmatic walkthrough to highlight the practical issues faced, more so than the overarching methodology or clinical area of interest. The paper presentation takes no more than 25 minutes, which leaves 10 minutes for questions from attendees.

How to participate

Access the meeting room here. You will need a password which can can be obtained by mailing us (members only).

We recommend testing the setup prior to the meeting by accessing the above link and clicking “Go to test site”.

All mics of participants will be muted centrally. In case of questions (during the last 10 minutes), please mark “raise your hand” and your mic will be centrally unmuted.


Last Friday of each month at 9.00 (only September-November and January-May)

DatePresenterPaperTheoretical topicLink to previous presentations
Sep 28Lina Steinrud MørchAssociation of Hormonal Contraception With Suicide Attempts and SuicidesSurveillance and healthy user biasPresentation
Oct 26Anton PottegårdUse of antipsychotics and risk of breast cancer: a Danish nationwide case-control study.Exposure ascertainment in cancer studiesPresentation
Jan 25Ellen LøkkegaardUsing prescription registries to define continuous drug use: how to fill gaps between prescriptions.Conditioning on the future in pharmacoepidemiology
Feb 28Marie HergraveMaternal use of fertility drugs and risk of cancer in children—A nationwide population‐based cohort study in DenmarkSeperating effects of the treatment from the underlying disease
Mar 22Kasper AdelborgUse of histamine H2 receptor antagonists and outcomes in patients with heart failure: a nationwide population-based cohort studyNew-user active comparator cohort studies
Scroll to top